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SObjective: The present study compared the outcomes between patients who had undergone video-assisted thor-
acoscopic surgery (VATS) thymectomy and transsternal (TS) thymectomy for Masaoka stage I and II thymoma.
Methods: The outcomes of 262 patients without myasthenia gravis who had undergone surgery for Masaoka
stage I and II thymoma from January 2008 to December 2012 at our center were retrospectively evaluated.
The study included 125 patients who had undergone unilateral VATS thymectomy (VATS group) and 137
patients who had undergone TS thymectomy (TS group).
Results: The VATS group had a shorter operative time than the TS group (170 vs 210 minutes, P<.001). The
VATS group also had a smaller intraoperative blood loss (200 vs 450 mL, P<.001), smaller pleural drainage
volume in the first 24 hours postoperatively (300 vs 500 mL, P<.0010), shorter postoperative pleural drainage
duration (3 vs 5 days, P<.001), and shorter postoperative hospital stay (8 vs 10 days, P<.001). Four patients in
the VATS group underwent conversion to open surgery because of injury to the innominate vein. The postoper-
ative complication rate was similar between the 2 groups. One patient in the VATS group developed pleural
recurrence, and one in the TS group developed local recurrence.
Conclusions: Unilateral VATS thymectomy for Masaoka stage I and II thymoma is technically feasible and safe
and is less invasive than TS thymectomy, with a shorter duration of surgery, less intraoperative blood loss, less
postoperative pleural drainage, shorter postoperative pleural drainage duration, and shorter postoperative hospital
stay. We have concluded that it is preferable to perform VATS thymectomy, although perhaps under certain
circumstances sternotomy might be preferred. The oncologic outcomes were comparable between the 2 proce-
dures. Additional follow-up is required to evaluate the long-term outcomes. (J Thorac Cardiovasc Surg
2014;147:1599-603)G
TSeveral studies have reported that video-assisted thoraco-
scopic surgery (VATS) thymectomy results in less operative
trauma, a shorter hospital stay, better preservation of pulmo-
nary function, and better cosmetic outcomes than transster-
nal (TS) thymectomy.1,2 However, it remains unclear
whether VATS or TS thymectomy would be preferable in
patients with noninvasive thymoma.3,4 A recent systematic
review concluded that the current evidence regarding the
long-term outcomes of minimally invasive surgery for thy-
moma is insufficient.5 The largest previously reported series
comparing open and minimally invasive thymectomy
included 77 patients who had undergone minimally invasive
thymectomy, some ofwhomhad undergone thymectomy for
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The Journal of Thoracic and Carbetween VATS and TS thymectomy in patients without
myasthenia gravis have been reported. The benefit of
VATS thymectomy needs to be defined. The purpose of
our studywas to retrospectively compare the early outcomes




The records of all 612 patients who had undergone resection of a pri-
mary thymic tumor with curative intent at Shanghai Chest Hospital from
January 2008 to December 2012 were retrospectively reviewed. Of these,
304 patients with a pathologic diagnosis of Masaoka stage I thymoma
(macroscopically and microscopically completely encapsulated) or stage
II thymoma (microscopic transcapsular invasion, macroscopic invasion
into the mediastinal fat, or grossly adherent to, but not through, the medi-
astinal pleura)6 had undergone unilateral VATS or TS thymectomy. A pa-
thology specialist reviewed all the pathology data from the standard
reports in the records. After exclusion of the 42 patients with myasthenia
gravis, the remaining 262 patients (139 men and 123 women) were
included in the present study. Of the 262 patients, 125 had undergone uni-
lateral VATS thymectomy and 137 had undergone TS thymectomy. The
characteristics of the patients in the VATS and TS groups are listed in
Table 1. No significant differences were found between these 2 groups in
age, gender, tumor stage, or the proportion of patients who underwent post-
operative adjuvant radiotherapy. No patient received preoperative neoadju-
vant therapy. No patient with Masaoka stage I thymoma received
postoperative adjuvant therapy. All patients with stage II thymoma were
offered postoperative adjuvant radiotherapy (total, 4000 cGy), but thisdiovascular Surgery c Volume 147, Number 5 1599
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Swas refused by some patients. The study was conducted in accordancewith
the principles of the Declaration of Helsinki, and the ethics committee of
Shanghai Chest Hospital, Shanghai Jiaotong University, approved the
study protocol. All patients provided written informed consent for surgery.
Because of the retrospective nature of the study, the requirement for patient
consent for inclusion in the present study was waived.
Operative Procedures
Nine surgeons performed all the thymectomy procedures during the
study period. These surgeons all performed both VATS and TS thymec-
tomy. The choice of procedurewas determined by the tumor characteristics
and surgeon preference. TS thymectomywas performed in all patients with
a tumor>5 cm in diameter. Total thymectomy, with resection of all perithy-
mic fat according to the Masaoka criteria, was performed in all patients.7
For unilateral VATS thymectomy, the patients were placed in the supine
position under general anesthesia. The tracheawas intubatedwith a double-
lumen tube for split-lung ventilation. If the tumor was located centrally or
on the right side, the right side of the chest was tilted upward by 30. If the
tumor was located on the left side, the left side of the chest was tilted up-
ward by 30. Surgery was performed through the side of the chest that was
tilted upward, using a 3-port technique. A thoracoscope was introduced
through a port in the fourth intercostal space at the posterior axillary
line, at a 30 oblique angle. Under direct vision, two 5-mm instrument ports
were placed: one in the third intercostal space at the midaxillary line and
the other in the sixth intercostal space at the anterior axillary line. In young
female patients, the ports were sometimes placed in the submammary fold
for cosmetic reasons. Dissection was performed as previously described.8
Starting on the side away from the tumor, care was taken to keep the plane
of dissection beyond the capsule, to avoid direct traction to the capsule, and
to limit capsular tears and local and pleural contamination by neoplastic
cells. The dissection plane was extended cranially, taking care to avoid
injury to the phrenic nerve. The left portion of the thymus was mobilized
from the pericardium overlying the ascending aorta. The thymic veins
were clipped and divided using ultrasonic or electrocautery dissection,
and the right and left thymic horns were dissected. The specimen was
removed in a plastic retrieval bag.
For TS thymectomy, the patients were placed in the supine position with
the arms tucked in or slightly away from the body. The trachea was intu-
bated with a single-lumen tube. Through complete or partial sternotomy,
the thymus and tumor were resected en bloc. One chest tube was left in
the patients of both groups, and the chest tube was removed when the chest
tube drainage had been<100 mL within 24 hours.
Data Collection
The surgery duration, intraoperative blood loss volume, pleural
drainage volume within the first 24 hours after surgery, postoperative
pleural drainage duration, postoperative hospital stay duration, and inci-
dence of postoperative complications and recurrence were recorded. The
tumor stage and tumor diameter were determined from the postoperative
pathologic reports. Recurrence was determined from the follow-up chest
contrast-enhanced computed tomography findings at 6 and 12 months after
surgery and annually thereafter.
Statistical Analysis
The data are reported as the mean  standard deviation or median and
range. Statistical analyses were performed using the Statistical Package for1600 The Journal of Thoracic and Cardiovascular SurSocial Sciences, version 16.0, statistical software (SPSS, Inc, Chicago, Ill).
The data were compared between the VATS and TS groups using the un-
paired t test, Fisher’s exact test, or Mann-Whitney U test, as appropriate.
Propensity score matching using logistic regression analysis was per-
formed to compare the groups after adjustment for gender, age, tumor
stage, and adjuvant therapy.RESULTS
The VATS group included 65 men and 60 women, with a
mean age of 51.9 years and median follow-up period of 41
months (range, 1-60). The TS group included 74 men and
63 women, with a mean age of 50.0 years and median
follow-up period of 42 months (range, 1-60). No patients
were lost to follow-up during the study period.
In the VATS group, 90 patients underwent surgery
through the right side and 35 through the left side. The peri-
operative outcomes of the patients in the VATS and TS
groups are listed in Table 1. The VATS group had a signif-
icantly shorter surgery duration, smaller intraoperative
blood loss volume, smaller pleural drainage volume within
24 hours after surgery, shorter postoperative pleural
drainage duration, and shorter postoperative hospital stay
than the TS group (P<.001 for all). Propensity score match-
ing using logistic regression analysis showed that these
variables all remained significantly different between the
2 groups after adjustment for gender, age, tumor stage, tu-
mor size, and adjuvant therapy (Table 2).
Four patients in the VATS group underwent conversion to
open surgery after injury to the left or right innominate vein,
which caused massive bleeding in 3 cases. The characteris-
tics of these 4 patients are listed in Table 3. Univariate logis-
tic regression analyses identified only older age (odds ratio,
1.343; 95% confidence interval, 1.3053-1.712; P ¼ .02),
larger tumor diameter (odds ratio, 1.277; 95% confidence
interval, 1.002-1.629; P ¼ .05), and stage II disease (odds
ratio, 6211; 95% confidence interval, 5.714-6752000;
P ¼ .01) as significant predictors of conversion to open
surgery.
Postoperative complications included 3 cases of pneu-
monia, 1 case of pleural effusion, and 1 case of pulmonary
atelectasis in the TS group and 1 case of pneumonia, 1 case
of pleural effusion, 1 case of wound infection, and 3 case of
pulmonary atelectasis in the VATS group. The difference in
the complication rate between the 2 groups was not signif-
icant. In both groups, all surgical margins were free of
tumor. No perioperative deaths occurred.
One patient in the VATS group developed pleural recur-
rence 42 months after surgery. This patient had had
Masaoka stage II thymoma and had undergone postopera-
tive adjuvant radiotherapy. One patient in the TS group
developed local (pericardial) recurrence at 36 months after
surgery. This patient had had Masaoka stage II thymoma
and had initially refused postoperative adjuvant radio-
therapy. These patients both underwent radiotherapy forgery c May 2014
FIGURE 1. Patients who underwent video-assisted thoracoscopic thy-
mectomy and transsternal thymectomy during each year of the study.
TABLE 1. Characteristics and surgical outcomes




















Adjuvant RT (Masaoka II) .529*
Yes 40/5 41/6
No
Surgery duration (min) <.001z
Median 170 210
Range 90-230 130-350
Blood loss (mL) <.001z
Median 200 450
Range 50-1500 200-700
Postoperative pleural drainage (d) <.001z
Median 3 5
Range 2-5 3-7
Postoperative hospital stay (d) <.001z
Median 8 10
Range 4-10 5-32
Conversion to open surgery 4 —
Blood transfusion 3 2 .672*
Postoperative complications 6 5 .643*
30-d Readmission 9 10 .975*




Recurrence 1 1 1
Data presented as n, mean  standard deviation, or median and range. VATS, Video-
assisted thoracoscopic (thymectomy); TS, transsternal (thymectomy); WHO, World
Health Organization; RT, radiotherapy. *Fisher’s exact test. yt Test. zMann-Whitney
U test.
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Stheir recurrence and were alive at the last follow-up exam-
ination but with additional disease progression.
DISCUSSION
Although TS thymectomy has been the traditional refer-
ence standard for the treatment of thymoma,9-13 VATS
thymectomy has been increasing in popularity. At our
institute, an increasing proportion of patients withThe Journal of Thoracic and CarMasaoka stage I and II thymoma have been undergoing
VATS thymectomy. This procedure has the advantage of
being minimally invasive and provides an excellent view of
the anterior mediastinum, allowing the surgeon to perform
total thymectomy with resection of the perithymic fat. In
the present series, the VATS group had a shorter surgery
duration, smaller blood loss volume, smaller postoperative
pleural drainage volume, shorter postoperative pleural
drainage period, and shorter postoperative hospital stay
than did the TS group. Furthermore, no serious
postoperative complications occurred in the VATS group.
These results indicate that unilateral VATS thymectomy is
safe and feasible for the treatment of patients with stage I
or II thymoma.
The optimal extent of surgical resection for the treatment
of Masaoka stage I or II thymoma remains unclear. Some
studies have concluded that complete resection of the tumor
was desirable but did not distinguish between total thymec-
tomy and partial thymectomy.14-16 Some studies have
reported that complete resection of the tumor was
sufficient for patients with Masaoka stage I and II
thymoma who did not have myasthenia gravis.17,18 Wide
resection of the thymus might increase the risk of surgical
complications, and it is unclear whether wide resection is
necessary in patients with small lesions. However, some
reports have advocated total thymectomy because of the
occasional development of recurrence.19,20 The incidence
of multicentric tumor development has been estimated to
be about 2%.21 It will usually be easy to diagnose the recur-
rence of thymoma using computed tomography, and pa-
tients with recurrence in the residual thymus should
undergo completion thymectomy.22 Completion thymec-
tomy can be more safely performed after thoracoscopic sur-
gery than after sternotomy.23
Only 4 patients in the VATS group underwent conversion
to open surgery. These 4 patients had all undergone surgery
during 2008 or 2009 and required conversion to open sur-
gery after injury to the left or right innominate vein caused
by electrocautery dissection. The drainage veins from the
thymus to the innominate vein are thin vessels, and we
now carefully isolate and clip each vessel and use ultrasonicdiovascular Surgery c Volume 147, Number 5 1601
FIGURE 2. Median duration of surgery in patients who underwent video-
assisted thoracoscopic thymectomy and transsternal thymectomy during
each year of the study.
TABLE 3. Characteristics of 4 patients who required conversion from
VATS to open surgery
Variable Value











Surgery duration (min) 205  20.8












Postoperative hospital stay (d) 6.8  2.2
VATS, Video-assisted thoracoscopic surgery.
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Scoagulation to minimize bleeding. Despite the massive
bleeding in 3 of these patients, the intraoperative blood
loss was significantly less in the VATS group than in the
TS group.
In our experience, VATS thymectomy allowed safe resec-
tion without damage to the thymoma capsule. However, the
size of the lesion will probably affect the success of the
minimally invasive approach. In the present series, the
mean diameter of the thymoma was 32.3  8.7 mm in the
VATS group and 33.8  6.5 mm in the TS group, similar
to the size reported in other series comparing these
procedures.8,24
VATS thymectomy has limitations but relatively few con-
traindications. In addition to the general contraindications
such as severe coagulopathy, the specific contraindications
include pleural adhesions and patients with severe underly-
ing lung disease or poor lung function who are unable to
tolerate selective single-lung ventilation.1 VATS might not
be an ideal approach for very young children because of
the difficulty of performing single-lung ventilation in this
age group.1
The long-term oncologic outcomes after VATS thymec-
tomy for thymoma remain unclear. Some studies have re-
ported tumor spread to the chest cavity after surgery.21,25
A comparative study of 40 patients by Pennathur andTABLE 2. Adjusted surgical outcomes for potentially confounding
factors
Variable VATS group TS group P value
Blood loss (mL) 183.1  98.2 462.4  95.7 <.001
Surgery duration (min) 171.0  31.1 216.0  41.2 <.001
Postoperative pleural
drainage within 24 h (mL)
311.8  122.0 496.6  112.7 <.001
Postoperative pleural
drainage duration (d)
3.2  0.8 4.9  0.9 <.001
Postoperative hospital stay (d) 7.3  1.5 12.36  7.6 <.001
P value by covariance analysis. VATS, Video-assisted thoracoscopic (thymectomy);
TS, transsternal (thymectomy).
1602 The Journal of Thoracic and Cardiovascular Surcolleagues8 reported no significant differences in disease
recurrence or overall survival between the VATS and TS
groups after a mean follow-up period of 36 months. Cheng
and colleagues26 observed no local or pleural recurrence af-
ter resection of stage II thymoma in either the VATS or TS
group. A recent systematic review of surgical resection for
thymoma reported a 5-year survival rate of 89% to 100% in
patients with stage I thymoma and 71% to 95% in patients
with stage II thymoma. In the present series, 1 patient devel-
oped pericardial recurrence and 1 developed pleural recur-
rence; both patients were still alive at the latest follow-up
visit. The oncologic outcomes were, therefore, comparable
between the VATS and TS groups in the intermediate term,
consistent with previously reported results. However, thy-
moma requires long-term follow-up because of the slow-
growing nature of the disease.19 Additional studies with
larger numbers of patients and 10 years of follow-up are
required to evaluate the long-term survival and disease-
free rates.Study Limitations
The present study was limited by its retrospective single-
center design and relatively short follow-up period. The sur-
gical procedure performed and the decision to convert to
open surgery were at the discretion of the surgeon, which
might have resulted in selection bias. The team of surgeons
who performed the operations was quite large and was agery c May 2014
Ye et al General Thoracic Surgerybias of the present study. Our series had a limited number of
cases, and the follow-up duration was not long enough.
These preliminary results of our series suggest that VATS
for Masaoka stage I and II thymoma is technically feasible
and safe and is less invasive for the patient. Nevertheless,
this procedure requires additional investigation in a large
series with longer follow-up. More cases series should be
investigated to establish the validity of our procedure.
However, our findings are important, because this is the
largest reported series comparing unilateral VATS thymec-
tomy with TS thymectomy for the treatment of Masaoka
stage I or II thymoma in patients without myasthenia gravis.SCONCLUSIONS
The results of the present study have shown that unilat-
eral VATS thymectomy is safe and feasible for the treatment
of Masaoka stage I or II thymoma. VATS thymectomy was
associated with a shorter postoperative hospital stay, less in-
traoperative blood loss, less postoperative pleural drainage,
and shorter postoperative pleural drainage duration than TS
thymectomy. We have concluded that it is preferable to
perform VATS thymectomy, although perhaps under certain
circumstances sternotomy might be preferred. The
intermediate-term oncologic outcomes were similar be-
tween the VATS and TS thymectomy groups. Additional
follow-up is required to evaluate the long-term outcomes
of VATS thymectomy for early-stage thymoma.G
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